Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2021.04.13
VOLUNTARY ANNOUNCEMENT - "INHIXA" OBTAINS APPROVAL FROM NORTH MACEDONIA
2021.04.09
VOLUNTARY ANNOUNCEMENT SETTLEMENT OF THE DISPOSAL OF SHARES OF KYMAB
2021.04.01
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3...
2021.03.29
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2020
2021.03.15
DATE OF BOARD MEETING
2021.03.01
Monthly Return of Equity Issuer on Movements in Securities for the month ended 2...
2021.02.02
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3...
2021.01.11
VOLUNTARY ANNOUNCEMENT DISPOSAL OF SHARES OF KYMAB
2021.01.05
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 3...
2020.12.15
POLL RESULTS OF THE 2020 FOURTH EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 1...
第一页
上一页
16
17
18
19
20
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
